Improvement of the immunochromatographic NG-Test CARBA5 assay for the detection of IMP-variants previously undetected.
Here, we evaluated the immunochromatographic assay, NG-Test Carba 5v2 (NG-Biotech), with improved IMP-variants detection, on 31 IMP-producers representing the different branches of the IMP-phylogeny, 32 OXA-48-, 19 KPC-, 12 VIM-, 14 NDM-, 13 multiple carbapenemase-producers (CPs), 13 none targeted CPs and 13 carbapenemase negative isolates. All tested IMP-variants were accurately detected, without impairing detection of the other carbapenemases. Thus, NG-Test CARBA5v2 is now well adapted to countries with high IMP-prevalence and to the epidemiology of CP-P. aeruginosa where IMPs are mostly detected.